The immune modulatory function of M. smegmatis preparation in animals with different immune status

Chinese Journal of Microbiology and Immunology

Volumn 25, Issue 9, 2005, Pages 752-755

  Xu, Miao ^a   Chen, Bao Wen ^b   Shen, Xiao Bing ^b   Su, Cheng ^b   Luo, Yong Ai ^b   Wang, Guo Zhi ^b  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b NONE

Author keywords

M. Smegmatis preparation; Two way immune modulation

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOBACTERIUM VACCINE;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG SYNTHESIS; GUINEA PIG; IMMUNE STATUS; IMMUNOMODULATION; INJECTION; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SERUM; SWINE; T LYMPHOCYTE;

EID: 28344442492     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Filion MC, Filion B, Reader S, et al. Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex. Cancer Immunol Immunother, 2000, 49(6): 325-334.
2. Labidi AH, Estes RC, David HL, et al. Mycobacterium recombinant vaccines. Tunis Med, 2001, 79(2): 65-81.
3. Faldt J, Dahlgren C, Ridell M. Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria. APMIS, 2002, 110(9): 593-600.
4. Rook GA, Seah G, Ustianowski A. M. tuberculosis: immunology and vaccination. Eur Respir J, 2001, 17(3): 537-557.
5. Jo EK, Park JK, Dockrell HN. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Diseases, 2003, 16(3): 205-210.
6. Bosio CM, Orme IM. Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacteruun bovis infections in mice. Infect Immun, 1998, 66(10): 5048-5051.